ACEIs, ARBs, beta-blockers could prevent chemo-related cardiotoxicity
11 Dec 2019
byRoshini Claire Anthony
Patients undergoing chemotherapy for breast or haematological cancers could potentially reduce their risk of chemotherapy-related cardiotoxicity with the use of angiotensin-converting enzyme (ACE) inhibitors, angiotensin II receptor antagonists (ARBs), or beta-blockers as primary prevention, according to a systematic review and meta-analysis presented at the recent EuroEcho 2019 conference.
ACEIs, ARBs, beta-blockers could prevent chemo-related cardiotoxicity
11 Dec 2019